COVAXIN submits phase-3 trial data for WHO approval: Reports
New Delhi: India's indigenous COVID vaccine Covaxin has submitted its phase-3 clinical trial data to WHO on Wednesday, for its ...
New Delhi: India's indigenous COVID vaccine Covaxin has submitted its phase-3 clinical trial data to WHO on Wednesday, for its ...